Increasing access to affordable medications is the cornerstone of CVS Health’s commitment to helping people on their path to better health. In early 2017, we announced the availability of a more affordable epinephrine auto-injector for people with life-threatening allergies. Now, we are now offering a new prescription savings program to help patients with high out-of-pocket costs afford their essential medications.
The new Reduced Rx™ prescription savings program will offer discounts on certain medications directly to patients through CVS Caremark, our pharmacy benefits manager.
Through the Reduced Rx prescription savings program, patients with diabetes will be able to purchase Novo Nordisk’s Novolin R®, Novolin N® and Novolin 70/30® human insulin at a cost of $25 per 10ml vial, which reflects a potential savings of as much as $100 for cash-paying patients.
Similarly, we offer the authorized generic of the Adrenaclick epinephrine auto-injector at a cash price of $109.99, the lowest in the market today. Additional cost reductions are available for qualifying patients who use the coupon program offered through the product’s manufacturer Impax, which offers an additional savings of $100 per pack.